These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Phenothiazine therapy and plasma immunoreactive beta-MSH in schizophrenia and pruritic dermatoses. Author: Smith AG, Goolamali SK, Thody AJ, Shuster S, Pye RJ, Burton JL. Journal: Br J Dermatol; 1977 May; 96(5):537-9. PubMed ID: 871390. Abstract: Plasma immunoreactive beta-melanocyte-stimulating hormone (beta-MSH) concentrations were normal in schizophrenic patients on prolonged and high dosage phenothiazine therapy. A group of patients treated with chlorpromazine 25 mg three times daily for pruritic dermatoses also showed no significant change in plasma beta-MSH concentration.[Abstract] [Full Text] [Related] [New Search]